Stockscreener 앱 받기
5.52
1.43%
-0.08
전일 마감가:
$5.60
열려 있는:
$5.6
하루 거래량:
117.74K
Relative Volume:
0.13
시가총액:
$190.49M
수익:
$59.63M
순이익/손실:
$-72.21M
주가수익비율:
-2.6286
EPS:
-2.1
순현금흐름:
$-30.85M
1주 성능:
+3.56%
1개월 성능:
+44.88%
6개월 성능:
+50.82%
1년 성능:
-2.30%
1일 변동 폭
$5.40
$5.66
1주일 범위
$5.20
$5.7298
52주 변동 폭
$1.81
$7.4802
908 디바이시스 Stock (MASS) Company Profile
명칭
908 Devices Inc
전화
978-729-4478
주소
645 SUMMER STREET, BOSTON
MASS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MASS
908 Devices Inc
|
5.52 | 190.49M | 59.63M | -72.21M | -30.85M | -2.10 |
|
ABT
Abbott Laboratories
|
132.26 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.55 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.49 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.41 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.32 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
908 디바이시스 Stock (MASS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-13 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-02-07 | 개시 | Stephens | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-01-12 | 개시 | Cowen | Outperform |
| 2021-01-12 | 개시 | SVB Leerink | Outperform |
| 2021-01-12 | 개시 | Stifel | Buy |
| 2021-01-12 | 개시 | William Blair | Outperform |
모두보기
908 디바이시스 주식(MASS)의 최신 뉴스
LPL Financial LLC Grows Stake in 908 Devices Inc. (NASDAQ:MASS) - Defense World
Geode Capital Management LLC Raises Stock Holdings in 908 Devices Inc. (NASDAQ:MASS) - Defense World
908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection - 01net
Why 908 Devices Inc. (MASS) is Surging in 2025 - Insider Monkey
XTX Topco Ltd Buys Shares of 52,196 908 Devices Inc. (NASDAQ:MASS) - Defense World
Repligen Corporation Q1 2025 Financial Results - TradingView
908 Devices receives $2M order from the Texas Department of Public Safety for drug detection and mitigation - Police1
908 Devices (NASDAQ:MASS) Receives “Sell (D-)” Rating from Weiss Ratings - Defense World
Market Insights: 908 Devices Inc (MASS)’s Notable Drop of -4.59, Closing at 5.40 - DWinneX
MASS’s Market Whiplash: 157.27% YTD Rise, 24.94% Rise in 30 Days - investchronicle.com
Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue - Yahoo Finance
908 Devices Inc. Receives $2 Million Order from the Texas Department of Public Safety for Drug Detection and Mitigation - marketscreener.com
Lobbying Update: $22,500 of 908 DEVICES INC. lobbying was just disclosed - Nasdaq
An Analysis Of 908 Devices Inc (MASS) Stock - Marketing Sentinel
MASS’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com
908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation - 01net
908 Devices Gets $2 Million Order From Texas for Drug Detection Tools - marketscreener.com
908 Devices (MASS) Secures $2M Order from Texas Department of Pu - GuruFocus
908 Devices rises after $2 million order from Texas Department of Public Safety - TradingView
908 Devices (MASS) Secures $2M Order from Texas Department of Public Safety | MASS Stock News - GuruFocus
908 Devices Receives $2M Order From The Texas Department Of Public Safety For Drug Detection And Mitigation - marketscreener.com
908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation | MASS Stock News - GuruFocus
908 Devices Receives $2M Order from the Texas Department of Publ - GuruFocus
908 Devices Inc. - firehouse.com
Stifel maintains Buy on 908 Devices, price target steady at $6 - Investing.com Canada
908 Devices reports 55% revenue jump in Q1 By Investing.com - Investing.com South Africa
908 Devices Announces Preliminary First Quarter 2025 Financial Results - BioSpace
908 Devices expects Q1 revenue below estimates - MSN
908 Devices reports preliminary Q1 revenue $11.5M. consensus $11.9M - TipRanks
908 Devices Announces Preliminary First Quarter 2025 Financial R - GuruFocus
908 Devices Announces Preliminary Q1 2025 Financial Results - marketscreener.com
908 Devices reports 55% revenue jump in Q1 - Investing.com
908 Devices Surges with 55% Growth: Q1 Revenue Hits $11.5M After Strategic Portfolio Shift - Stock Titan
Prudential Financial Inc. Makes New Investment in 908 Devices Inc. (NASDAQ:MASS) - Defense World
908 Devices Leads These 3 Penny Stocks To Consider - Yahoo Finance
908 Devices (NASDAQ:MASS) Earns Sell (D-) Rating from Weiss Ratings - Defense World
The Zacks Analyst Blog Highlights Fidelity NASDAQ Composite Index ETF, ThredUp, 908 Devices, Logility Supply Chain, Palomar and EZCORP - TradingView
908 Devices stock soars on divestiture and revenue growth By Investing.com - Investing.com Nigeria
Charles Schwab Investment Management Inc. Has $444,000 Stake in 908 Devices Inc. (NASDAQ:MASS) - Defense World
908 Devices (NASDAQ:MASS) Given Sell (E+) Rating at Weiss Ratings - Defense World
Q1 Earnings Estimate for 908 Devices Issued By William Blair - Defense World
Best Momentum Stocks to Buy for March 13th - Yahoo Finance
908 Devices (MASS) Stock Jumps on Strength of New Order Announcement - Stocks Telegraph
908 Devices gets $1.7M order from Ministry of Health of Ukraine - MSN
908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device - 01net
908 Devices climbs on $1.7 mln order from Ukraine - TradingView
908 Devices secures $1.7 million order from Ukraine - Investing.com India
908 Devices secures $1.7 million order from Ukraine By Investing.com - Investing.com South Africa
908 Devices Receives $1.7M Order From The Ministry Of Health Of Ukraine For Its Handheld Mass Spec Device - Marketscreener.com
What Is The Outlook For 908 Devices Inc (NASDAQ: MASS) Like For Short-Term? - Stocks Register
908 Devices: Strategic Divestiture and Strong Financial Performance Drive Buy Rating - TipRanks
908 디바이시스 (MASS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
908 디바이시스 주식 (MASS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Turner Michael S. | Chief Legal & Admin Officer |
Feb 03 '25 |
Sale |
2.33 |
9,672 |
22,499 |
24,603 |
| Knopp Kevin J. | President and CEO |
Feb 03 '25 |
Sale |
2.32 |
16,001 |
37,109 |
692,733 |
| Brown Christopher D. | Chief Product Officer |
Feb 03 '25 |
Sale |
2.34 |
7,767 |
18,191 |
962,122 |
| Brown Christopher D. | Chief Product Officer |
Dec 19 '24 |
Option Exercise |
1.58 |
55,131 |
87,107 |
946,453 |
| Knopp Kevin J. | President and CEO |
Dec 13 '24 |
Option Exercise |
1.63 |
158,044 |
257,771 |
667,025 |
| Brown Christopher D. | Chief Product Officer |
Aug 07 '24 |
Option Exercise |
1.58 |
6,328 |
9,998 |
891,322 |
| Eisenberg Marcia | Director |
Jun 07 '24 |
Option Exercise |
0.00 |
682 |
0 |
6,816 |
| Knopp Kevin J. | President and CEO |
May 13 '24 |
Buy |
6.42 |
10,000 |
64,200 |
508,981 |
| Knopp Kevin J. | President and CEO |
May 10 '24 |
Buy |
5.77 |
10,000 |
57,700 |
498,981 |
| Knopp Kevin J. | President and CEO |
May 09 '24 |
Buy |
5.83 |
10,000 |
58,300 |
488,981 |
10.11%
0.14%
자본화:
|
볼륨(24시간):